As the world gears towards sustainability, Monique Suryokusumo from Monde Nissin Corporation shares about the current innovations in the alternative protein space and the key factors that will...
A macro view. by Vanessa Huang Charles Li’s vision that HKEX can be the largest biotech IPO venue in the next five to ten years may sound ambitious, but when we look at the numbers and the context...
Newly formed Novotech Health Holdings will serve Asia to meet the rapidly growing demand for quality clinical trial services in the region. Starting October 2020, Novetech and PPC Group, two Asian...
Singapore-based clinical-stage biotechnology company, Tychan announces results for Phase 1 Trial for TY014, a novel monoclonal antibody candidate treatment for yellow fever. Results of Phase 1 trial...
Innovative biotherapeutics company, Hummingbird Bioscience announced a partnership with Mycenax Biotech to produce anti-VISTA antibody, HMBD-002 for use in Phase I clinical trials of its HMBD-002...
At 15,000 sq. ft., NSG BioLabs is the largest centre of its kind and will offer companies and entrepreneurs with a flexible and fully-equipped environment that can help biotech firms and investors...
New wheat genotype is safe for consumption for people with celiac disease. Researchers at Washington State University have created a new, genetically distinct variety of wheat that is safer for...
Led by the growth of biomedicine sector. For the first time, the total output of South Korea’s biotech industry topped 10 trillion won (US$9 billion) in 2017. This was largely led by the growth of...
Chinese drug developers to compete with multinational drug companies, give rise to more innovation. China, with its reformed priority review and approval processes, is supporting biotech revolution...
